Skip to main content
. 2017 Sep 16;8(46):81662–81678. doi: 10.18632/oncotarget.20953

Table 6. Clinical trials with Temsirolimus in head and neck cancer patients.

Compound Combination Phase State NCT number
Temsirolimus Paclitaxel + Carboplatin 1/2 Not yet recruiting NCT01016769
/ 2 Completed NCT01172769
/ unknown Completed NCT00195299
Cetuximab 2 Completed NCT01256385
Erlotinib 2 Completed NCT01009203
Cetuximab + Cisplatin + RT Pilot Withdrawn NCT01326468
Cetuximab + Cisplatin 1/2 Terminated NCT01015664

RT: Radiotherapy, NCT: Number clinicaltrials.gov identifier.